TRANDOLAPRIL (trandolapril) by Teva is angiotensin-converting enzyme inhibitors [moa]. Approved for angiotensin converting enzyme inhibitor [epc]. First approved in 2006.
Drug data last refreshed 19h ago
Angiotensin-converting Enzyme Inhibitors
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients
Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fed Conditions
Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fasting Conditions
Trandolapril 4 mg Tablet Under Fasting Conditions
Trandolapril 4 mg Tablet Under Non-Fasting Conditions
Worked on TRANDOLAPRIL at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.